Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,334
datasets available to search
ShareScore release 0.9.0
Dataset results
1,334 results for “Hematology”
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers
ClinicalTrials.gov study NCT01135329. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)
ClinicalTrials.gov study NCT01139164. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multi
ClinicalTrials.gov study NCT06258629. IPD Sharing: UNDECIDED. Countries: 0. Publications: 4.
A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies
ClinicalTrials.gov study NCT06508489. IPD Sharing: YES. Countries: 2. Publications: 0.
GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies
ClinicalTrials.gov study NCT04824794. IPD Sharing: NO. Countries: 20. Publications: 0.
Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
ClinicalTrials.gov study NCT00555048. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Pharmacokinetics (PK), And Hematological Activity Of AMD3100 (Plerixafor) In Subjects With Renal Impairment
ClinicalTrials.gov study NCT00445302. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT01028716. IPD Sharing: NO. Countries: 1. Publications: 0.
Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab
ClinicalTrials.gov study NCT04312841. IPD Sharing: NO. Countries: 1. Publications: 0.
TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, R
ClinicalTrials.gov study NCT03615144. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT01119066. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Helicobacter Pylori and it's Hematological Impact
ClinicalTrials.gov study NCT03629587. IPD Sharing: NO. Countries: 0. Publications: 8.
Some Hematological Profile in Children With Chronic Kidney Disease
ClinicalTrials.gov study NCT06143098. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
ClinicalTrials.gov study NCT01233921. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
ClinicalTrials.gov study NCT00134004. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Spectrum of Hematological Disorders in Pediatrics
ClinicalTrials.gov study NCT05473650. IPD Sharing: Not stated. Countries: 0. Publications: 7.
The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies
ClinicalTrials.gov study NCT00001432. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
ClinicalTrials.gov study NCT00276159. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders
ClinicalTrials.gov study NCT00547196. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT07285668. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.